Expandable metallic ureteral stent: Indications and results

Research output: Contribution to journalReview article

Abstract

INTRODUCTION: Ureteral obstructions are managed by complex surgery not always feasible for surgical field complexity or poor patient conditions. Various surgical maneuvers, as ureteral dilation, stenting and percutaneous nephrostomy, can be offered, but they are related to considerable failure rates and negative impact on quality of life. In selected cases, the positioning of long-term expandable metallic ureteral stents (EMUSs) may be an appropriate and successful choice. EVIDENCE ACQUISITION: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria, a systematic review of the literature was performed in July 2017 using PubMed, Cochrane Library, Scopus and Web of Science databases. The search was conducted by typing the following terms: “Expandable metallic ureteral stent,” “Memokath ureteral stent,” “Allium ureteral stent,” and “Uventa ureteral stent.” EVIDENCE SYNTHESIS: Twenty studies reported the safety, efficacy and clinical outcomes related to the common available EMUSs. Most studies were single-arm, retrospective and involving a low number of clinical cases, resulting in significant difficulties with outlining indications and drawing conclusions. Available papers showed EMUSs offered a high rate of patency, a long duration and a good quality of life, even if they are associated with significant complications. CONCLUSIONS: Since the first description of ureteral stents 50 years ago, we have faced a significant evolution in stent design. The current generation of EMUSs offers many advantages, but the onset of adverse effects is still significant and limits their use to selected cases. Further research should be addressed to the realization of prospective, multi-institutional randomized clinical trials to highlight indications to manage appropriately ureteral obstructions.

Original languageEnglish
Pages (from-to)275-285
Number of pages11
JournalMinerva Urologica e Nefrologica
Volume70
Issue number3
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Stents
Ureteral Obstruction
Quality of Life
Allium
Percutaneous Nephrostomy
PubMed
Libraries
Meta-Analysis
Dilatation
Randomized Controlled Trials
Databases
Safety
Research

Keywords

  • Self expandable metallic stents
  • Stents
  • Ureteral diseases
  • Ureteral obstruction

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Expandable metallic ureteral stent : Indications and results. / Sampogna, Gianluca; Grasso, Angelica; Montanari, Emanuele.

In: Minerva Urologica e Nefrologica, Vol. 70, No. 3, 01.06.2018, p. 275-285.

Research output: Contribution to journalReview article

@article{2c224065208e4ee592697e252fde271d,
title = "Expandable metallic ureteral stent: Indications and results",
abstract = "INTRODUCTION: Ureteral obstructions are managed by complex surgery not always feasible for surgical field complexity or poor patient conditions. Various surgical maneuvers, as ureteral dilation, stenting and percutaneous nephrostomy, can be offered, but they are related to considerable failure rates and negative impact on quality of life. In selected cases, the positioning of long-term expandable metallic ureteral stents (EMUSs) may be an appropriate and successful choice. EVIDENCE ACQUISITION: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria, a systematic review of the literature was performed in July 2017 using PubMed, Cochrane Library, Scopus and Web of Science databases. The search was conducted by typing the following terms: “Expandable metallic ureteral stent,” “Memokath ureteral stent,” “Allium ureteral stent,” and “Uventa ureteral stent.” EVIDENCE SYNTHESIS: Twenty studies reported the safety, efficacy and clinical outcomes related to the common available EMUSs. Most studies were single-arm, retrospective and involving a low number of clinical cases, resulting in significant difficulties with outlining indications and drawing conclusions. Available papers showed EMUSs offered a high rate of patency, a long duration and a good quality of life, even if they are associated with significant complications. CONCLUSIONS: Since the first description of ureteral stents 50 years ago, we have faced a significant evolution in stent design. The current generation of EMUSs offers many advantages, but the onset of adverse effects is still significant and limits their use to selected cases. Further research should be addressed to the realization of prospective, multi-institutional randomized clinical trials to highlight indications to manage appropriately ureteral obstructions.",
keywords = "Self expandable metallic stents, Stents, Ureteral diseases, Ureteral obstruction",
author = "Gianluca Sampogna and Angelica Grasso and Emanuele Montanari",
year = "2018",
month = "6",
day = "1",
doi = "10.23736/S0393-2249.18.03035-7",
language = "English",
volume = "70",
pages = "275--285",
journal = "Minerva Urologica e Nefrologica",
issn = "0393-2249",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Expandable metallic ureteral stent

T2 - Indications and results

AU - Sampogna, Gianluca

AU - Grasso, Angelica

AU - Montanari, Emanuele

PY - 2018/6/1

Y1 - 2018/6/1

N2 - INTRODUCTION: Ureteral obstructions are managed by complex surgery not always feasible for surgical field complexity or poor patient conditions. Various surgical maneuvers, as ureteral dilation, stenting and percutaneous nephrostomy, can be offered, but they are related to considerable failure rates and negative impact on quality of life. In selected cases, the positioning of long-term expandable metallic ureteral stents (EMUSs) may be an appropriate and successful choice. EVIDENCE ACQUISITION: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria, a systematic review of the literature was performed in July 2017 using PubMed, Cochrane Library, Scopus and Web of Science databases. The search was conducted by typing the following terms: “Expandable metallic ureteral stent,” “Memokath ureteral stent,” “Allium ureteral stent,” and “Uventa ureteral stent.” EVIDENCE SYNTHESIS: Twenty studies reported the safety, efficacy and clinical outcomes related to the common available EMUSs. Most studies were single-arm, retrospective and involving a low number of clinical cases, resulting in significant difficulties with outlining indications and drawing conclusions. Available papers showed EMUSs offered a high rate of patency, a long duration and a good quality of life, even if they are associated with significant complications. CONCLUSIONS: Since the first description of ureteral stents 50 years ago, we have faced a significant evolution in stent design. The current generation of EMUSs offers many advantages, but the onset of adverse effects is still significant and limits their use to selected cases. Further research should be addressed to the realization of prospective, multi-institutional randomized clinical trials to highlight indications to manage appropriately ureteral obstructions.

AB - INTRODUCTION: Ureteral obstructions are managed by complex surgery not always feasible for surgical field complexity or poor patient conditions. Various surgical maneuvers, as ureteral dilation, stenting and percutaneous nephrostomy, can be offered, but they are related to considerable failure rates and negative impact on quality of life. In selected cases, the positioning of long-term expandable metallic ureteral stents (EMUSs) may be an appropriate and successful choice. EVIDENCE ACQUISITION: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria, a systematic review of the literature was performed in July 2017 using PubMed, Cochrane Library, Scopus and Web of Science databases. The search was conducted by typing the following terms: “Expandable metallic ureteral stent,” “Memokath ureteral stent,” “Allium ureteral stent,” and “Uventa ureteral stent.” EVIDENCE SYNTHESIS: Twenty studies reported the safety, efficacy and clinical outcomes related to the common available EMUSs. Most studies were single-arm, retrospective and involving a low number of clinical cases, resulting in significant difficulties with outlining indications and drawing conclusions. Available papers showed EMUSs offered a high rate of patency, a long duration and a good quality of life, even if they are associated with significant complications. CONCLUSIONS: Since the first description of ureteral stents 50 years ago, we have faced a significant evolution in stent design. The current generation of EMUSs offers many advantages, but the onset of adverse effects is still significant and limits their use to selected cases. Further research should be addressed to the realization of prospective, multi-institutional randomized clinical trials to highlight indications to manage appropriately ureteral obstructions.

KW - Self expandable metallic stents

KW - Stents

KW - Ureteral diseases

KW - Ureteral obstruction

UR - http://www.scopus.com/inward/record.url?scp=85049959395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049959395&partnerID=8YFLogxK

U2 - 10.23736/S0393-2249.18.03035-7

DO - 10.23736/S0393-2249.18.03035-7

M3 - Review article

AN - SCOPUS:85049959395

VL - 70

SP - 275

EP - 285

JO - Minerva Urologica e Nefrologica

JF - Minerva Urologica e Nefrologica

SN - 0393-2249

IS - 3

ER -